glp-1 and ckd Real-World Evidence for Receptor Agonists Across the Spectrum – AJKD Blog Potential kidney-protective and other effects

Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies

Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p=0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p=0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p=0.0315)

This foundational nutrition helps ensure the body continues receiving essential micronutrients during dietary changes

Tirzepatide and gastroparesis share symptoms

Can taking Wegovy and Zepbound change your menstrual cycle